NRX Pharmaceuticals (NRXP) Cash from Investing Activities (2017 - 2026)
NRX Pharmaceuticals' (NRXP) quarterly Cash from Investing Activities came in at -$213000.0 in Q1 2026, up 14.46% on a QoQ basis from -$249000.0 in Q4 2025.
NRX Pharmaceuticals (NRXP) Cash from Investing Activities (2017 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 9 years of Cash from Investing Activities data on file, last reported at -$213000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$213000.0 in Q1 2026; TTM through Mar 2026 was -$462000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$2.8 million, changed N/A from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$213000.0, up from -$249000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for NRXP reached as high as $2000.0 in Q2 2023 and fell as low as -$249000.0 in Q4 2025.
- Historically, Cash from Investing Activities has averaged -$47500.0 across 4 years, with a median of -$3000.0 in 2022.
- On a YoY basis, Cash from Investing Activities climbed as much as 166.67% in 2023 and fell as far as 33.33% in 2023.
- Year by year, Cash from Investing Activities stood at $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then slumped by 25000.0% to -$249000.0 in 2025, then climbed by 14.46% to -$213000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$213000.0 in Q1 2026, -$249000.0 in Q4 2025, and $1000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 172.62 Mn |
| 10 | NRX Pharmaceuticals | 117.34 Mn | 110.64 Mn | 437,000.00 | -213,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -213,000.00 |
| Mar 31, 2026 | -213,000.00 |
| Dec 31, 2025 | -249,000.00 |
| Dec 31, 2025 | -249,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | -5,000.00 |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -3,000.00 |
| Jun 30, 2022 | -3,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Mar 31, 2022 | -3,000.00 |